JPRN-UMIN000042064
Completed
Phase 1
Phase I/II clinical trial to evaluate the efficacy and safety of DFP-17729 in patients with unresectable/recurrent/progressive pancreatic cancer - Phase I/II clinical trial of DFP-17729
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Delta-Fly Pharma, Inc.
- Enrollment
- 39
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patient without 1\)Obvious infection 2\)Severe heart diseases 3\)Severe complicatios 4\)Brain metasitases 5\)Severe digestive diseases 6\)Severe thromboembolisms 7\)Severe diarrhea 8\)Severe psychosis 9\)Double cancer 10\)Pregnant woman/ Breastfeeding 11\)Continuous systemic administration of steroids 12\)Effects of pretreatment 13\)Blood transfusion and blood component preparation 14\)Patients judged to be inappropriate
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A Phase II clinical trial to evaluate the efficacy and safety of intra-arterial infusion chemotherapy for head and neck squamous cell carcinomahead and neck squamous cell carcinomaJPRN-UMIN000019865Department of Otorhinolaryngology, Head and Neck Surgery, Graduate School of Medicine, Chiba University40
Recruiting
Phase 1/2
Trial evaluating the safety and efficacy of Venetoclax in addition to a standard conditioning regime in patients with certain forms of leukemia undergoing allogeneic blood stem cell transplantation2024-514688-24-00Heinrich-Heine-Universitaet Duesseldorf38
Recruiting
Phase 1
Trial evaluating the safety and efficacy of Venetoclax in addition to a standard conditioning regime in patients with certain forms of leukemia undergoing allogeneic blood stem cell transplantatioCTIS2024-514688-24-00Heinrich-Heine-Universitaet Duesseldorf38
Active, not recruiting
Phase 1
Clinical trial to evaluate the effectiveness and safety of acetazolamide in the treatment of cerebellar syndrome in patients with phosphomannomutase deficiency.Cerebellar syndromeMedDRA version: 19.1Level: PTClassification code 10008072Term: Cerebellar syndromeSystem Organ Class: 10029205 - Nervous system disordersTherapeutic area: Diseases [C] - Nervous System Diseases [C10]EUCTR2017-000810-44-ESFundació Sant Joan de Déu30
Active, not recruiting
Not Applicable
Phase II clinical trial to evaluate the efficacy and safety in the use of pancreatic islets cells from cadaver donors for the treatment of Type-I Diabetes Mellitus in renal transplant patients.Type-I Diabetes Mellitus in renal trasplant patientsMedDRA version: 8.1Level: ptClassification code 10061835EUCTR2005-004523-19-ESÁrea de Trasplante y Terapia Celular - Hospital Central de Asturias10